Demo Sign up Log In

Esperion Therapeutics Inc (ESPR)

CapEx to Revenue

0.24%

Quarterly · Period ending: Mar 31, 2026

ESPR CapEx to Revenue

Latest reported0.24%period endingMar 31, 2026

Latest reported0.24%period endingMar 31, 2026

ESPR Quarterly CapEx/Revenue (12356.40% → 0.24%)

Latest values, visible window

High-resolution chart · PNG

ESPR capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Esperion Therapeutics Inc CapEx to Revenue — Quarterly
Period ending	CapEx to Revenue
Mar 31, 2026	0.2359%
Dec 31, 2025	0.1122%
Sep 30, 2025	0%
Jun 30, 2025	0%
Mar 31, 2025	0%
Dec 31, 2024	0%
Sep 30, 2024	0.3234%
Jun 30, 2024	0.1043%
Mar 31, 2024	0.053%
Dec 31, 2023	0%
Sep 30, 2023	0%
Jun 30, 2023	0%
Mar 31, 2023	0%
Dec 31, 2022	0%
Sep 30, 2022	0%
Jun 30, 2022	0%
Mar 31, 2022	0%
Dec 31, 2021	0%
Sep 30, 2021	0%
Jun 30, 2021	0%
Mar 31, 2021	0%
Dec 31, 2020	1.8261%
Sep 30, 2020	2.1654%
Jun 30, 2020	0.2756%
Mar 31, 2020	10.3804%
Dec 31, 2019	17.5153%
Sep 30, 2019	36.4934%
Jun 30, 2019	23.8289%
Mar 31, 2019	0.13%
Dec 31, 2018	0.0569%
Sep 30, 2018	0%
Jun 30, 2018	0%
Mar 31, 2018	0%
Dec 31, 2017	0%
Sep 30, 2017	0%
Jun 30, 2017	0%
Mar 31, 2017	0%
Dec 31, 2016	0%
Sep 30, 2016	0%
Jun 30, 2016	0%
Mar 31, 2016	0%
Dec 31, 2015	0%
Sep 30, 2015	0%
Jun 30, 2015	0%
Mar 31, 2015	0%
Dec 31, 2014	0%
Sep 30, 2014	0%
Jun 30, 2014	0%
Mar 31, 2014	0%
Dec 31, 2013	0%
Sep 30, 2013	0%
Jun 30, 2013	0%
Mar 31, 2013	0%
Dec 31, 2012	0%
Sep 30, 2012	0%
Jun 30, 2012	0%
Mar 31, 2012	0%
Sep 30, 2003	0%
Jun 30, 2003	0%
Mar 31, 2003	0%
Dec 31, 2002	0%
Sep 30, 2002	0%
Jun 30, 2002	0%
Mar 31, 2002	0%
Dec 31, 2001	0%
Sep 30, 2001	0%
Jun 30, 2001	24,400%
Mar 31, 2001	40,500%
Dec 31, 2000	55,600%
Sep 30, 2000	27,500%
Jun 30, 2000	38,643.6%
Mar 31, 2000	12,356.4%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.